Cardiac Assist Devices (CAD) Global Market – Forecast To 2027

Publishing Date : June, 2021
Report Code : HCMD0155
Price:
Single license $4,950
Site license $6,750
Global license $9,000


Note: The report would be dispatched after confirmation of payment

 

The heart conditions are considered advanced or end-stage heart failure when conventional heart therapies and management strategies no longer work. The reduced ability of the heart to pump blood and maintain normal bodily function leads to heart failure. Heart transplantation is currently the preferred treatment for end-stage heart failure. The availability of donor heart is insufficient to meet the required demand and many patients are not eligible for transplantation due to age and other health conditions. The Cardiac assist devices (CAD) i.e., Ventricular Assist Devices (VAD), Total Artificial Heart (TAH), and Intra-Aortic Balloon Pump (IABP) are used to treat various conditions related to the heart such as end-stage heart failure, refractory angina pectoris, post-cardiopulmonary bypass shock, myocardial infarction, myocarditis and others. The ventricular assist device is a mechanical pump that supports heart function and blood flow by reducing the workload of the left ventricle, right ventricle, or both left and right ventricles helping the heart to pump oxygenated blood to the rest of the body. The indication for VAD use is acute cardiogenic shock (post-cardiac surgery, myocarditis, and massive myocardial infarction) and chronic heart failure. Percutaneous Ventricular Assist Devices (PVADs) to provide hemodynamic support in patients undergoing high-risk percutaneous coronary intervention (PCI). PVADs are often used as temporary support in left ventricular failure patients who are assisted for LVAD implantation. An artificial heart (TAH) is a mechanical assist device for people with biventricular heart failure and heart transplant candidate which replaces both native ventricles and all four chambers of the heart, thereby eliminating the symptoms of cardiac insufficiency or heart failure. Intra-aortic balloon pump (IABP) is placed in the aorta to help the heart to pump more blood by reducing the workload on the heart and improves the function of the left ventricle as this is the chamber that pumps blood into the aorta. IABP is used in conditions such as acute mitral valve regurgitation or severe heart failure, left ventricular failure, unstable angina and others.

According to IQ4I Analysis, the CAD global market is expected to grow at a high single digit CAGR from 2020 to 2027 to reach $4,813.5 million by 2027. Cardiac Assist Devices based on product type are segmented into Ventricular assist device (VAD), Total Artificial Heart (TAH), and Intra-Aortic Balloon Pump (IABP) among which VAD commanded the largest share in 2020 and is expected to grow at a strong double digit CAGR from 2020 to 2027.  Ventricular assist device is sub-segmented into Left Ventricular Assist Devices (LVAD), Right Ventricular Assist Devices (RVAD), and Biventricular Assist Devices (Bi-VAD). Among this, LVAD commanded the largest revenue in 2020 and is expected to grow at a strong double digit CAGR from 2020 to 2027. CAD market based on pump type is segmented into Pulsatile Pump and Continuous Flow Pump, among which, continuous flow pump segment commanded the largest share in 2020 and is expected to grow at double digit CAGR from 2020 to 2027. The continuous flow pump is further segmented into axial flow pump and Centrifugal flow pump, the axial flow pump generated the largest revenue in 2020 and is expected to grow at a strong double digit CAGR from 2020 to 2027. CAD market based on implant type is segmented into Extracorporeal CAD, Intracorporeal CAD, and Percutaneous CAD, among these, percutaneous CAD generated the largest revenue in 2020 and is expected grow at a strong double digit CAGR from 2020 to 2027. CAD market based on patient type is segmented into Adult and Pediatric, among which, adult market commanded the largest revenue in 2020. The CAD application market is classified as Bridge to Transplant (BTT), Bridge to destination (BTD), Bridge to Recovery (BTR), and Bridge to Candidacy (BTC) among which Bridge to recovery (BTR) commanded the largest share in 2020 and is expected to grow at a strong double digit CAGR from 2020 to 2027.

Some of the key players of the Cardiac assist devices are Abbott Laboratories (U.S.), Medtronic PLC (Ireland), Abiomed, Inc (U.S.), Reliant Heart, Inc (U.S.), Fresenius Medical Care AG & Co. KGaA Care AG & Co. KGaA (Germany), Getinge Group (Sweden), Syncardia Systems LLC (U.S.), Zeon Corporation (Japan), Teleflex Incorporated (U.S.) and others.

  • 1     EXECUTIVE SUMMARY
  • 2     INTRODUCTION
    • 2.1     KEY TAKEAWAYS
    • 2.2     REPORT DESCRIPTION
    • 2.3     MARKETS COVERED
    • 2.4     STAKEHOLDERS
    • 2.5     RESEARCH METHODOLOGY
      • 2.5.1     MARKET SIZE ESTIMATION
      • 2.5.2     MARKET BREAKDOWN AND DATA TRIANGULATION
      • 2.5.3     SECONDARY SOURCES
      • 2.5.4     PRIMARY SOURCES
      • 2.5.5     KEY DATA POINTS FROM SECONDARY SOURCES
      • 2.5.6     KEY DATA POINTS FROM PRIMARY SOURCES
      • 2.5.7     ASSUMPTIONS
  • 3     MARKET ANALYSIS
    • 3.1     INTRODUCTION
    • 3.2     MARKET SEGMENTATION
    • 3.3     FACTORS INFLUENCING MARKET
      • 3.3.1     DRIVERS AND OPPORTUNITIES
        • 3.3.1.1     INCREASING INCIDENCE OF HEART FAILURE
        • 3.3.1.2     SHORTAGE OF HEART DONORS
        • 3.3.1.3     TECHNOLOGICAL ADVANCEMENTS IN CAD
        • 3.3.1.4     RISING GERIATRIC POPULATION
        • 3.3.1.5     VAST PIPELINE PRODUCTS
        • 3.3.1.6     INCREASE IN FUNDING FOR CAD RESEARCH
      • 3.3.2     RESTRAINTS AND THREATS
        • 3.3.2.1     ADVERSE EVENTS AND COMPLICATION WITH THE IMPLANTATIONS OF CAD
        • 3.3.2.2     COST OF THE DEVICES
        • 3.3.2.3     LACK OF SKILLED AND TRAINED PROFESSIONALS
        • 3.3.2.4     STRINGENT REGULATORY GUIDELINES
        • 3.3.2.5     AVAILABILITY OF ALTERNATIVE PRODUCTS
    • 3.4     REGULATORY AFFAIRS
      • 3.4.1     INTERNATIONAL ORGANIZATION FOR STANDARDIZATION
        • 3.4.1.1     ISO 9001: 2015 QUALITY MANAGEMENT SYSTEM
        • 3.4.1.2     ISO 14644-1 CLEANROOM STANDARDS
        • 3.4.1.3     ISO 13485 MEDICAL DEVICES
        • 3.4.1.4     ISO 10993 BIOLOGICAL EVALUATION OF MEDICAL DEVICES
        • 3.4.1.5     ISO 14971: RISK MANAGEMENT OF MEDICAL DEVICES
        • 3.4.1.6     ISO 14708-5: ACTIVE IMPLANTABLE MEDICAL DEVICES - PART 5: CIRCULATORY SUPPORT DEVICES
        • 3.4.1.7     IEC 60601-1 MEDICAL ELECTRICAL EQUIPMENT STANDARD
        • 3.4.1.8     IEC 60601-1-11 HOME CARE SAFETY
      • 3.4.2     U.S.
      • 3.4.3     CANADA
      • 3.4.4     EUROPE
      • 3.4.5     CHINA
      • 3.4.6     JAPAN
      • 3.4.7     INDIA
    • 3.5     REIMBURSEMENT SCENARIO
      • 3.5.1     REIMBURSEMENT TABLE
        • 3.5.1.1     VENTRICULAR ASSIST DEVICE REIMBURSEMENT
        • 3.5.1.2     CAD PHYSICIAN REIMBURSEMENT
    • 3.6     FUNDING SCENARIO
    • 3.7     UPCOMING TECHNOLOGY
    • 3.8     CLINICAL TRIAL DATA
    • 3.9     PATENT TRENDS
    • 3.10     TECHNOLOGICAL ADVANCEMENTS
      • 3.10.1     INTRODUCTION
      • 3.10.2     EXTRA AORTIC BALLOON PUMP
      • 3.10.3     NON-BLOOD-CONTACTING CADS
      • 3.10.4     MUSCLE POWERED VADS
    • 3.11     PORTER’S FIVE FORCE ANALYSIS
      • 3.11.1     THREAT OF NEW ENTRANTS
      • 3.11.2     THREAT OF SUBSTITUTES
      • 3.11.3     BARGAINING POWER OF SUPPLIERS
      • 3.11.4     BARGAINING POWER OF BUYERS
      • 3.11.5     COMPETITIVE RIVALRY
    • 3.12     PERCUTANEOUS VENTRICULAR ASSIST DEVICE (PVAD) MARKET PENETRATION
      • 3.12.1     U.S. PERCUTANEOUS VENTRICULAR ASSIST DEVICE (PVAD) MARKET PENETRATION ANALYSIS
      • 3.12.2     U.K. PERCUTANEOUS VENTRICULAR ASSIST DEVICE (PVAD) MARKET PENETRATION ANALYSIS
      • 3.12.3     GERMANY PERCUTANEOUS VENTRICULAR ASSIST DEVICE (PVAD) MARKET PENETRATION ANALYSIS
      • 3.12.4     FRANCE PERCUTANEOUS VENTRICULAR ASSIST DEVICE (PVAD) MARKET PENETRATION ANALYSIS
      • 3.12.5     JAPAN PERCUTANEOUS VENTRICULAR ASSIST DEVICE (PVAD) MARKET PENETRATION ANALYSIS
    • 3.13     INTRA-AORTIC BALLOON PUMP (IABP) MARKET PENETRATION
      • 3.13.1     U.S. INTRA-AORTIC BALLOON PUMP (IABP) MARKET PENETRATION ANALYSIS
      • 3.13.2     U.K. INTRA-AORTIC BALLOON PUMP (IABP) MARKET PENETRATION ANALYSIS
      • 3.13.3     GERMANY INTRA-AORTIC BALLOON PUMP (IABP) MARKET PENETRATION ANALYSIS
      • 3.13.4     FRANCE INTRA-AORTIC BALLOON PUMP (IABP) MARKET PENETRATION ANALYSIS
      • 3.13.5     JAPAN INTRA-AORTIC BALLOON PUMP (IABP) MARKET PENETRATION ANALYSIS
    • 3.14     SUPPLY CHAIN ANALYSIS
    • 3.15     MARKET SHARE ANALYSIS BY MAJOR PLAYERS
      • 3.15.1     CARDIAC ASSIST DEVICES (CAD) GLOBAL MARKET SHARE ANALYSIS
      • 3.15.2     VENTRICULAR ASSIST DEVICES (VAD) GLOBAL MARKET SHARE ANALYSIS
      • 3.15.3     INTRA-AORTIC BALLOON PUMP (IABP) GLOBAL MARKET SHARE ANALYSIS
    • 3.16     CARDIAC ASSIST DEVICES NUMBER OF UNITS SOLD BY REGION
      • 3.16.1     VENTRICULAR ASSIST DEVICES NUMBER OF UNITS SOLD BY REGION
        • 3.16.1.1     VENTRICULAR ASSIST DEVICES (VAD) NUMBER OF UNITS SOLD
        • 3.16.1.2     PERCUTANEOUS VENTRICULAR ASSIST DEVICES NUMBER OF UNITS SOLD
      • 3.16.2     IABP DEVICES GLOBAL NUMBER OF UNITS SOLD BY REGION
      • 3.16.3     TOTAL ARTIFICIAL HEART NUMBER OF UNITS BY REGION
      • 3.16.4     COMPANYWISE VAD NUMBER OF UNITS SOLD (2020)
    • 3.17     COMPARISON OF CARDIAC ASSIST DEVICES
  • 4     CARDIAC ASSIST DEVICES GLOBAL MARKET, BY PRODUCT
    • 4.1     INTRODUCTION
    • 4.2     VENTRICULAR ASSIST DEVICES (VAD)
      • 4.2.1     LEFT VENTRICULAR ASSIST DEVICES (LVAD)
      • 4.2.2     RIGHT VENTRICULAR ASSIST DEVICES (RVAD)
      • 4.2.3     BI-VENTRICULAR ASSIST DEVICES (BI-VAD)
    • 4.3     INTRA-AORTIC BALLOON PUMPS (IABP)
    • 4.4     TOTAL ARTIFICIAL HEART (TAH)
  • 5     CARDIAC ASSIST DEVICES GLOBAL MARKET, BY IMPLANT TYPE
    • 5.1     INTRODUCTION
    • 5.2     EXTRACORPOREAL OR PARACORPOREAL CAD
    • 5.3     INTRACORPOREAL CAD
    • 5.4     PERCUTANEOUS CAD
  • 6     CARDIAC ASSIST DEVICES GLOBAL MARKET, BY PUMP TYPE
    • 6.1     INTRODUCTION
    • 6.2     PULSATILE FLOW PUMP
    • 6.3     CONTINUOUS FLOW PUMP
      • 6.3.1     CENTRIFUGAL FLOW PUMP
      • 6.3.2     AXIAL FLOW PUMP
  • 7     CARDIAC ASSIST DEVICES GLOBAL MARKET, BY PATIENT TYPE
    • 7.1     INTRODUCTION
    • 7.2     PEDIATRIC CAD
    • 7.3     ADULT CAD
  • 8     CARDIAC ASSIST DEVICES GLOBAL MARKET, BY APPLICATION
    • 8.1     INTRODUCTION
    • 8.2     CAD TREATMENT FLOW CHART
    • 8.3     BRIDGE TO TRANSPLANT (BTT)
    • 8.4     BRIDGE TO DESTINATION THERAPY (BTD)
    • 8.5     BRIDGE TO RECOVERY (BTR)
    • 8.6     BRIDGE TO CANDIDACY (BTC)
  • 9     REGIONAL ANALYSIS
    • 9.1     INTRODUCTION
    • 9.2     NORTH AMERICA
      • 9.2.1     THE U.S.
      • 9.2.2     REST OF NORTH AMERICA
    • 9.3     EUROPE
      • 9.3.1     GERMANY
      • 9.3.2     FRANCE
      • 9.3.3     U.K.
      • 9.3.4     REST OF EUROPE
    • 9.4     APAC
      • 9.4.1     JAPAN
      • 9.4.2     CHINA
      • 9.4.3     INDIA
      • 9.4.4     REST OF APAC
    • 9.5     ROW
      • 9.5.1     BRAZIL
      • 9.5.2     REST OF LATIN AMERICA
      • 9.5.3     MIDDLE EAST AND OTHERS
  • 10     COMPANY DEVELOPMENTS
    • 10.1     INTRODUCTION
    • 10.2     APPROVALS
    • 10.3     AGREEMENTS AND JOINT VENTURES
    • 10.4     OTHER DEVELOPMENTS
  • 11     MAJOR COMPANIES
    • 11.1     ABBOTT LABORATORIES
      • 11.1.1     OVERVIEW
      • 11.1.2     FINANCIALS
      • 11.1.3     PRODUCT PORTFOLIO
      • 11.1.4     KEY DEVELOPMENTS
      • 11.1.5     BUSINESS STRATEGY
      • 11.1.6     SWOT ANALYSIS
    • 11.2     ABIOMED, INC.
      • 11.2.1     OVERVIEW
      • 11.2.2     FINANCIALS
      • 11.2.3     PRODUCT PORTFOLIO
      • 11.2.4     KEY DEVELOPMENTS
      • 11.2.5     BUSINESS STRATEGY
      • 11.2.6     SWOT ANALYSIS
    • 11.3     BERLIN HEART GMBH
      • 11.3.1     OVERVIEW
      • 11.3.2     FINANCIALS
      • 11.3.3     PRODUCT PORTFOLIO
      • 11.3.4     KEY DEVELOPMENTS
      • 11.3.5     BUSINESS STRATEGY
      • 11.3.6     SWOT ANALYSIS
    • 11.4     FRESENIUS MEDICAL CARE AG & CO. KGAA (XENIOS AG)
      • 11.4.1     OVERVIEW
      • 11.4.2     FINANCIALS
      • 11.4.3     PRODUCT PORTFOLIO
      • 11.4.4     KEY DEVELOPMENTS
      • 11.4.5     BUSINESS STRATEGY
      • 11.4.6     SWOT ANALYSIS
    • 11.5     GETINGE GROUP (MAQUET)
      • 11.5.1     OVERVIEW
      • 11.5.2     FINANCIALS
      • 11.5.3     PRODUCT PORTFOLIO
      • 11.5.4     KEY DEVELOPMENTS
      • 11.5.5     BUSINESS STRATEGY
      • 11.5.6     SWOT ANALYSIS
    • 11.6     LIVANOVA PLC
      • 11.6.1     OVERVIEW
      • 11.6.2     FINANCIALS
      • 11.6.3     PRODUCT PORTFOLIO
      • 11.6.4     KEY DEVELOPMENTS
      • 11.6.5     BUSINESS STRATEGY
      • 11.6.6     SWOT ANALYSIS
    • 11.7     MEDTRONIC, PLC
      • 11.7.1     OVERVIEW
      • 11.7.2     FINANCIALS
      • 11.7.3     PRODUCT PORTFOLIO
      • 11.7.4     KEY DEVELOPMENTS
      • 11.7.5     BUSINESS STRATEGY
      • 11.7.6     SWOT ANALYSIS
    • 11.8     SYNCARDIA SYSTEMS, LLC
      • 11.8.1     OVERVIEW
      • 11.8.2     FINANCIALS
      • 11.8.3     PRODUCT PORTFOLIO
      • 11.8.4     KEY DEVELOPMENTS
      • 11.8.5     BUSINESS STRATEGY
      • 11.8.6     SWOT ANALYSIS
    • 11.9     TELEFLEX INCORPORATED
      • 11.9.1     OVERVIEW
      • 11.9.2     FINANCIALS
      • 11.9.3     PRODUCT PORTFOLIO
      • 11.9.4     KEY DEVELOPMENTS
      • 11.9.5     BUSINESS STRATEGY
      • 11.9.6     SWOT ANALYSIS
    • 11.10     ZEON CORPORATION
      • 11.10.1     OVERVIEW
      • 11.10.2     FINANCIALS
      • 11.10.3     PRODUCT PORTFOLIO
      • 11.10.4     KEY DEVELOPMENTS
      • 11.10.5     BUSINESS STRATEGY
      • 11.10.6     SWOT ANALYSIS

      LIST OF TABLES

      • TABLE 1     CARDIAC ASSIST DEVICES GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
      • TABLE 2     VAD NUMBER OF UNITS SOLD, BY REGION, (2020) (NO’S)
      • TABLE 3     PERCUTANEOUS VAD NUMBER OF UNITS SOLD, BY REGION, (2019-2027) (NO’S)
      • TABLE 4     IABP NUMBER OF UNITS, BY REGION, (2019-2027) (NO’S)
      • TABLE 5     TOTAL ARTIFICIAL HEART NUMBER OF UNITS, BY REGION, (2019-2027) (NO’S)
      • TABLE 6     COMPANYWISE VAD NUMBER OF UNITS SOLD, (2020) (NO’S)
      • TABLE 7     CARDIAC ASSIST DEVICES GLOBAL MARKET REVENUE, BY PRODUCTS, (2019-2027) ($MN)
      • TABLE 8     VENTRICULAR ASSIST DEVICES GLOBAL MARKET REVENUE, BY PRODUCTS, (2019-2027) ($MN)
      • TABLE 9     VENTRICULAR ASSIST DEVICES GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
      • TABLE 10     VENTRICULAR ASSIST DEVICES GLOBAL MARKET REVENUE, BY IMPLANT TYPE, (2019-2027) ($MN)
      • TABLE 11     PARACORPOREAL VAD GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
      • TABLE 12     INTRACORPOREAL VAD GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
      • TABLE 13     PERCUTANEOUS VAD GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
      • TABLE 14     LEFT VENTRICULAR ASSIST DEVICES (LVAD) GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
      • TABLE 15     RIGHT VENTRICULAR ASSIST DEVICES (RVAD) GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
      • TABLE 16     BI-VENTRICULAR ASSIST DEVICES (BI-VAD) GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
      • TABLE 17     INTRA-AORTIC BALLOON PUMP GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
      • TABLE 18     TOTAL ARTIFICIAL HEART GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
      • TABLE 19     CARDIAC ASSIST DEVICES GLOBAL MARKET REVENUE, BY IMPLANT TYPE, (2019-2027) ($MN)
      • TABLE 20     EXTRACORPOREAL OR PARACORPOREAL CAD GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
      • TABLE 21     INTRACORPOREAL CAD GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
      • TABLE 22     PERCUTANEOUS CAD GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
      • TABLE 23     CARDIAC ASSIST DEVICES GLOBAL MARKET REVENUE, BY PUMP TYPE, (2019-2027) ($MN)
      • TABLE 24     PULSATILE FLOW PUMP GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
      • TABLE 25     CONTINUOUS FLOW PUMP GLOBAL MARKET REVENUE, BY PUMP TYPE, (2019-2027) ($MN)
      • TABLE 26     CONTINUOUS FLOW PUMP GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
      • TABLE 27     CENTRIFUGAL FLOW PUMP GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
      • TABLE 28     AXIAL FLOW PUMP GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
      • TABLE 29     CARDIAC ASSIST DEVICES GLOBAL MARKET REVENUE, BY PATIENT TYPE, (2019-2027) ($MN)
      • TABLE 30     PEDIATRIC CAD GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
      • TABLE 31     ADULT CAD GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
      • TABLE 32     CARDIAC ASSIST DEVICES GLOBAL MARKET REVENUE, BY APPLICATION, (2019-2027) ($MN)
      • TABLE 33     BRIDGE TO TRANSPLANT (BTT) GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
      • TABLE 34     BRIDGE TO DESTINATION THERAPY (BTD) GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
      • TABLE 35     BRIDGE TO RECOVERY (BTR) GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
      • TABLE 36     BRIDGE TO CANDIDACY (BTC) GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
      • TABLE 37     CARDIAC ASSIST DEVICES GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
      • TABLE 38     NORTH AMERICA CARDIAC ASSIST DEVICES MARKET REVENUE, BY PRODUCT, (2019-2027) ($MN)
      • TABLE 39     NORTH AMERICA VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY PRODUCT, (2019-2027) ($MN)
      • TABLE 40     NORTH AMERICA CARDIAC ASSIST DEVICES MARKET REVENUE, BY IMPLANT TYPE, (2019-2027) ($MN)
      • TABLE 41     NORTH AMERICA CARDIAC ASSIST DEVICES MARKET REVENUE, BY PUMP TYPE, (2019-2027) ($MN)
      • TABLE 42     NORTH AMERICA CONTINUOUS FLOW PUMP MARKET REVENUE, BY PUMP TYPE, (2019-2027) ($MN)
      • TABLE 43     NORTH AMERICA CARDIAC ASSIST DEVICES MARKET REVENUE, BY PATIENT TYPE, (2019-2027) ($MN)
      • TABLE 44     NORTH AMERICA CARDIAC ASSIST DEVICES MARKET REVENUE, BY APPLICATION, (2019-2027) ($MN)
      • TABLE 45     NORTH AMERICA CARDIAC ASSIST DEVICES MARKET REVENUE, BY COUNTRY, (2019-2027) ($MN)
      • TABLE 46     EUROPE CARDIAC ASSIST DEVICES MARKET REVENUE, BY PRODUCT, (2019-2027) ($MN)
      • TABLE 47     EUROPE VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY PRODUCT, (2019-2027) ($MN)
      • TABLE 48     EUROPE CARDIAC ASSIST DEVICES MARKET REVENUE, BY IMPLANT TYPE, (2019-2027) ($MN)
      • TABLE 49     EUROPE CARDIAC ASSIST DEVICES MARKET REVENUE, BY PUMP TYPE, (2019-2027) ($MN)
      • TABLE 50     EUROPE CONTINUOUS FLOW PUMP MARKET REVENUE, BY PUMP TYPE, (2019-2027) ($MN)
      • TABLE 51     EUROPE CARDIAC ASSIST DEVICES MARKET REVENUE, BY PATIENT TYPE, (2019-2027) ($MN)
      • TABLE 52     EUROPE CARDIAC ASSIST DEVICES MARKET REVENUE, BY APPLICATION, (2019-2027) ($MN)
      • TABLE 53     EUROPE CARDIAC ASSIST DEVICES MARKET REVENUE, BY COUNTRY, (2019-2027) ($MN)
      • TABLE 54     APAC CARDIAC ASSIST DEVICES MARKET REVENUE, BY PRODUCT, (2019-2027) ($MN)
      • TABLE 55     APAC VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY PRODUCT, (2019-2027) ($MN)
      • TABLE 56     APAC CARDIAC ASSIST DEVICES MARKET REVENUE, BY IMPLANT TYPE, (2019-2027) ($MN)
      • TABLE 57     APAC CARDIAC ASSIST DEVICES MARKET REVENUE, BY PUMP TYPE, (2019-2027) ($MN)
      • TABLE 58     APAC CONTINUOUS FLOW PUMP MARKET REVENUE, BY PUMP TYPE, (2019-2027) ($MN)
      • TABLE 59     APAC CARDIAC ASSIST DEVICES MARKET REVENUE, BY PATIENT TYPE, (2019-2027) ($MN)
      • TABLE 60     APAC CARDIAC ASSIST DEVICES MARKET REVENUE, BY APPLICATION, (2019-2027) ($MN)
      • TABLE 61     APAC CARDIAC ASSIST DEVICES MARKET REVENUE, BY COUNTRY, (2019-2027) ($MN)
      • TABLE 62     ROW CARDIAC ASSIST DEVICES MARKET REVENUE, BY PRODUCT, (2019-2027) ($MN)
      • TABLE 63     ROW VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY PRODUCT, (2019-2027) ($MN)
      • TABLE 64     ROW CARDIAC ASSIST DEVICES MARKET REVENUE, BY IMPLANT TYPE, (2019-2027) ($MN)
      • TABLE 65     ROW CARDIAC ASSIST DEVICES MARKET REVENUE, BY PUMP TYPE, (2019-2027) ($MN)
      • TABLE 66     ROW CONTINUOUS FLOW PUMP MARKET REVENUE, BY PUMP TYPE, (2019-2027) ($MN)
      • TABLE 67     ROW CARDIAC ASSIST DEVICES MARKET REVENUE, BY PATIENT TYPE, (2019-2027) ($MN)
      • TABLE 68     ROW CARDIAC ASSIST DEVICES MARKET REVENUE, BY APPLICATION, (2019-2027) ($MN)
      • TABLE 69     ROW CARDIAC ASSIST DEVICES MARKET REVENUE, BY COUNTRY, (2019-2027) ($MN)
      • TABLE 70     APPROVALS, (2020-2021)
      • TABLE 71     AGREEMENTS AND JOINT VENTURES (2020-2021)
      • TABLE 72     OTHER DEVELOPMENTS (2020-2021)
      • TABLE 73     ABBOTT LABORATORIES: TOTAL REVENUE AND R&D EXPENSES, (2019-2021) ($MN)
      • TABLE 74     ABBOTT LABORATORIES: TOTAL REVENUE BY SEGMENTS, (2019-2021) ($MN)
      • TABLE 75     ABBOTT LABORATORIES: TOTAL REVENUE BY GEOGRAPHY, (2019-2021) ($MN)
      • TABLE 76     ABIOMED: TOTAL REVENUE AND R&D EXPENSES, (2019-2021) ($MN)
      • TABLE 77     ABIOMED: TOTAL REVENUE, BY SEGMENTS, (2019-2021) ($MN)
      • TABLE 78     FRESENIUS MEDICAL CARE AG & CO. KGAA: TOTAL REVENUE AND R&D EXPENSES, (2019-2021) ($MN)
      • TABLE 79     FRESENIUS MEDICAL CARE AG & CO. KGAA: TOTAL REVENUE, BY SEGMENTS, (2019-2021) ($MN)
      • TABLE 80     FRESENIUS MEDICAL CARE AG & CO. KGAA: TOTAL REVENUE, BY GEOGRAPHY (2019-2021) ($MN)
      • TABLE 81     GETINGE GROUP: TOTAL REVENUE AND R&D EXPENSES, (2019-2021) ($MN)
      • TABLE 82     GETINGE GROUP: TOTAL REVENUE, BY SEGMENT, (2019-2021) ($MN)
      • TABLE 83     GETINGE GROUP: TOTAL REVENUE, BY GEOGRAPHY, (2019-2021) ($MN)
      • TABLE 84     LIVANOVA, PLC: TOTAL REVENUE AND R&D EXPENSES, (2019-2021) ($MN)
      • TABLE 85     LIVANOVA, PLC: TOTAL REVENUE, BY SEGMENTS, (2019-2021) ($MN)
      • TABLE 86     LIVANOVA, PLC: TOTAL REVENUE, BY GEOGRAPHY, (2019-2021) ($MN)
      • TABLE 87     MEDTRONIC, PLC: TOTAL REVENUE AND R&D EXPENSES, (2019-2021) ($MN)
      • TABLE 88     MEDTRONIC, PLC: TOTAL REVENUE, BY SEGMENTS, (2019-2021) ($MN)
      • TABLE 89     MEDTRONIC, PLC: CARDIAC & VASCULAR REVENUE, BY SUB-SEGMENTS, (2019-2021) ($MN)
      • TABLE 90     MEDTRONIC, PLC: TOTAL REVENUE, BY GEOGRAPHY, (2019-2021) ($MN)
      • TABLE 91     TELEFLEX INCORPORATED: TOTAL SALES AND R&D EXPENSES, (2019-2021) ($MN)
      • TABLE 92     TELEFLEX INCORPORATED: TOTAL SALES, BY SEGMENTS, (2019-2021) ($MN)
      • TABLE 93     TELEFLEX INCORPORATED: TOTAL SALES, BY GEOGRAPHY, (2019-2021) ($MN)
      • TABLE 94     ZEON CORPORATION: TOTAL REVENUE AND R&D EXPENSES, (2018-2020) ($MN)
      • TABLE 95     ZEON CORPORATION: TOTAL REVENUE, BY SEGMENTS, (2018-2020) ($MN)
      • TABLE 96     ZEON CORPORATION: TOTAL REVENUE, BY GEOGRAPHY, (2018-2020) ($MN)

      LIST OF FIGURES

      • FIGURE 1     CARDIAC ASSIST DEVICES GLOBAL MARKET REVENUE, BY REGION (2019-2027) ($MN)
      • FIGURE 2     RESEARCH METHODOLOGY: CARDIAC ASSIST DEVICES GLOBAL MARKET
      • FIGURE 3     CARDIAC ASSIST DEVICES GLOBAL MARKET: TOP-DOWN AND BOTTOM-UP APPROACH
      • FIGURE 4     CARDIAC ASSIST DEVICES GLOBAL MARKET: FORECASTING MODEL
      • FIGURE 5     CARDIAC ASSIST DEVICES GLOBAL MARKET: MARKET BREAKDOWN & DATA TRIANGULATION
      • FIGURE 6     CARDIAC ASSIST DEVICES GLOBAL MARKET SEGMENTATION
      • FIGURE 7     MARKET DYNAMICS
      • FIGURE 8     CARDIAC ASSIST DEVICES MARKET: PATENT FILING BY MAJOR PLAYERS (2017-2021)
      • FIGURE 9     CARDIAC ASSIST DEVICES GLOBAL MARKET: PORTER’S ANALYSIS
      • FIGURE 10     U.S. PVAD MARKET PENETRATION, (2020) (%)
      • FIGURE 11     U.K. PVAD MARKET PENETRATION, (2020) (%)
      • FIGURE 12     GERMANY PVAD MARKET PENETRATION, (2020) (%)
      • FIGURE 13     FRANCE PVAD MARKET PENETRATION, (2020) (%)
      • FIGURE 14     JAPAN PVAD MARKET PENETRATION, (2020) (%)
      • FIGURE 15     U.S. IABP MARKET PENETRATION, (2020) (%)
      • FIGURE 16     U.K. IABP MARKET PENETRATION, (2020) (%)
      • FIGURE 17     GERMANY IABP MARKET PENETRATION, (2020) (%)
      • FIGURE 18     FRANCE IABP MARKET PENETRATION, (2020) (%)
      • FIGURE 19     JAPAN IABP MARKET PENETRATION, (2020) (%)
      • FIGURE 20     CARDIAC ASSIST DEVICES GLOBAL MARKET: SUPPLY CHAIN ANALYSIS
      • FIGURE 21     CARDIAC ASSIST DEVICES (CAD) GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2020 (%)
      • FIGURE 22     VENTRICULAR ASSIST DEVICES (VAD) GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2020 (%)
      • FIGURE 23     INTRA-AORTIC BALLOON PUMP (IABP) GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2020 (%)
      • FIGURE 24     CARDIAC ASSIST DEVICES GLOBAL MARKET SHARE, BY PRODUCTS (2020 V/S 2027) (%)
      • FIGURE 25     VENTRICULAR ASSIST DEVICES GLOBAL MARKET SHARE, BY PRODUCTS (2020 V/S 2027) (%)
      • FIGURE 26     CARDIAC ASSIST DEVICES GLOBAL MARKET SHARE, BY IMPLANT TYPE (2020 V/S 2027) (%)
      • FIGURE 27     CARDIAC ASSIST DEVICES GLOBAL MARKET SHARE, BY PUMP TYPE (2020 V/S 2027) (%)
      • FIGURE 28     CONTINUOUS FLOW PUMP GLOBAL MARKET SHARE, BY PUMP TYPE (2020 V/S 2027) (%)
      • FIGURE 29     CARDIAC ASSIST DEVICES GLOBAL MARKET SHARE, BY PATIENT TYPE (2020 V/S 2027) (%)
      • FIGURE 30     CARDIAC ASSIST DEVICES GLOBAL MARKET SHARE, BY APPLICATION, (2020 V/S 2027) (%)
      • FIGURE 31      CAD TREATMENT FLOW CHART
      • FIGURE 32     CARDIAC ASSIST DEVICES GLOBAL MARKET REVENUE, BY REGION (2019-2027) ($MN), CAGR (%)
      • FIGURE 33     NORTH AMERICA CARDIAC ASSIST DEVICES MARKET SHARE, BY PRODUCTS, (2020 V/S 2027) (%)
      • FIGURE 34     NORTH AMERICA VENTRICULAR ASSIST DEVICES MARKET SHARE, BY PRODUCTS, (2020 V/S 2027) (%)
      • FIGURE 35     NORTH AMERICA CARDIAC ASSIST DEVICES MARKET SHARE, BY IMPLANT TYPE (2020 V/S 2027) (%)
      • FIGURE 36     NORTH AMERICA CARDIAC ASSIST DEVICES MARKET REVENUE, BY PUMP TYPE AND CONTINUOUS FLOW PUMP TYPE (2020) ($MN)
      • FIGURE 37     NORTH AMERICA CARDIAC ASSIST DEVICES MARKET SHARE, BY PATIENT TYPE (2020 V/S 2027) (%)
      • FIGURE 38     NORTH AMERICA CARDIAC ASSIST DEVICES MARKET SHARE, BY APPLICATION (2020 V/S 2027) (%)
      • FIGURE 39     NORTH AMERICA CARDIAC ASSIST DEVICES MARKET SHARE, BY COUNTRY, (2020 V/S 2027) (%)
      • FIGURE 40     U.S. CARDIAC ASSIST DEVICES (CAD) AND VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY PRODUCTS (2020 V/S 2027) ($MN)
      • FIGURE 41     U.S. CARDIAC ASSIST DEVICES MARKET REVENUE, BY IMPLANT TYPE/PUMP TYPE/PATIENT TYPE (2020 V/S 2027) ($MN)
      • FIGURE 42     U.S. CARDIAC ASSIST DEVICES MARKET REVENUE, BY APPLICATION TYPE (2020 V/S 2027) ($MN)
      • FIGURE 43     REST OF NORTH AMERICA CARDIAC ASSIST DEVICES (CAD) AND VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY PRODUCTS (2020 V/S 2027) ($MN)
      • FIGURE 44     REST OF NORTH AMERICA CARDIAC ASSIST DEVICES MARKET REVENUE, BY IMPLANT TYPE/PUMP TYPE/PATIENT TYPE (2020 V/S 2027) ($MN)
      • FIGURE 45     REST OF NORTH AMERICA CARDIAC ASSIST DEVICES MARKET REVENUE, BY APPLICATION (2020 V/S 2027) ($MN)
      • FIGURE 46     EUROPE CARDIAC ASSIST DEVICES MARKET SHARE, BY PRODUCTS, (2020 V/S 2027) (%)
      • FIGURE 47     EUROPE VENTRICULAR ASSIST DEVICES MARKET SHARE, BY PRODUCTS, (2020 V/S 2027) (%)
      • FIGURE 48     EUROPE CARDIAC ASSIST DEVICES MARKET SHARE, BY IMPLANT TYPE (2020 V/S 2027) (%)
      • FIGURE 49     EUROPE CARDIAC ASSIST DEVICES MARKET REVENUE, BY PUMP TYPE AND CONTINUOUS FLOW PUMP TYPE (2020) ($MN)
      • FIGURE 50     EUROPE CARDIAC ASSIST DEVICES MARKET SHARE, BY PATIENT TYPE (2020 V/S 2027) (%)
      • FIGURE 51     EUROPE CARDIAC ASSIST DEVICES MARKET SHARE, BY APPLICATION (2020 V/S 2027) (%)
      • FIGURE 52     EUROPE CARDIAC ASSIST DEVICES MARKET SHARE, BY COUNTRY, (2020 V/S 2027) (%)
      • FIGURE 53     GERMANY CARDIAC ASSIST DEVICES (CAD) AND VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY PRODUCTS (2020 V/S 2027) ($MN)
      • FIGURE 54     GERMANY CARDIAC ASSIST DEVICES MARKET REVENUE, BY IMPLANT TYPE/PUMP TYPE/PATIENT TYPE (2020 V/S 2027) ($MN)
      • FIGURE 55     GERMANY CARDIAC ASSIST DEVICES MARKET REVENUE, BY APPLICATION (2020 V/S 2027) ($MN)
      • FIGURE 56     FRANCE CARDIAC ASSIST DEVICES (CAD) AND VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY PRODUCTS (2020 V/S 2027) ($MN)
      • FIGURE 57     FRANCE CARDIAC ASSIST DEVICES MARKET REVENUE, BY IMPLANT TYPE/PUMP TYPE/PATIENT TYPE (2020 V/S 2027) ($MN)
      • FIGURE 58     FRANCE CARDIAC ASSIST DEVICES MARKET REVENUE, BY APPLICATION (2020 V/S 2027) ($MN)
      • FIGURE 59     U.K. CARDIAC ASSIST DEVICES (CAD) AND VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY PRODUCTS (2020 V/S 2027) ($MN)
      • FIGURE 60     U.K. CARDIAC ASSIST DEVICES MARKET REVENUE, BY IMPLANT TYPE/PUMP TYPE/PATIENT TYPE (2020 V/S 2027) ($MN)
      • FIGURE 61     U.K. CARDIAC ASSIST DEVICES MARKET REVENUE, BY APPLICATION (2020 V/S 2027) ($MN)
      • FIGURE 62     REST OF EUROPE CARDIAC ASSIST DEVICES (CAD) AND VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY PRODUCTS (2020 V/S 2027) ($MN)
      • FIGURE 63     REST OF EUROPE CARDIAC ASSIST DEVICES MARKET REVENUE, BY IMPLANT TYPE/PUMP TYPE/PATIENT TYPE (2020 V/S 2027) ($MN)
      • FIGURE 64     REST OF EUROPE CARDIAC ASSIST DEVICES MARKET REVENUE, BY APPLICATION (2020 V/S 2027) ($MN)
      • FIGURE 65     APAC CARDIAC ASSIST DEVICES MARKET SHARE, BY PRODUCTS, (2020 V/S 2027) (%)
      • FIGURE 66     APAC VENTRICULAR ASSIST DEVICES MARKET SHARE, BY PRODUCTS, (2020 V/S 2027) (%)
      • FIGURE 67     APAC CARDIAC ASSIST DEVICES MARKET SHARE, BY IMPLANT TYPE (2020 V/S 2027) (%)
      • FIGURE 68     APAC CARDIAC ASSIST DEVICES MARKET REVENUE, BY PUMP TYPE AND CONTINUOUS FLOW PUMP TYPE (2020) ($MN)
      • FIGURE 69     APAC CARDIAC ASSIST DEVICES MARKET SHARE, BY PATIENT TYPE (2020 V/S 2027) (%)
      • FIGURE 70     APAC CARDIAC ASSIST DEVICES MARKET SHARE, BY APPLICATION (2020 V/S 2027) (%)
      • FIGURE 71     APAC CARDIAC ASSIST DEVICES MARKET SHARE, BY COUNTRY, (2020 V/S 2027) (%)
      • FIGURE 72     JAPAN CARDIAC ASSIST DEVICES (CAD) AND VENTRICULAR ASSIST DEVICES (VAD) MARKET REVENUE, BY PRODUCTS (2020 V/S 2027) ($MN)
      • FIGURE 73     JAPAN CARDIAC ASSIST DEVICES MARKET REVENUE, BY IMPLANT TYPE/PUMP TYPE/PATIENT TYPE (2020 V/S 2027) ($MN)
      • FIGURE 74     JAPAN CARDIAC ASSIST DEVICES MARKET REVENUE, BY APPLICATION (2020 V/S 2027) ($MN)
      • FIGURE 75     CHINA CARDIAC ASSIST DEVICES (CAD) AND VENTRICULAR ASSIST DEVICES (VAD) MARKET REVENUE, BY PRODUCTS (2020 V/S 2027) ($MN)
      • FIGURE 76     CHINA CARDIAC ASSIST DEVICES MARKET REVENUE, BY IMPLANT TYPE/PUMP TYPE/PATIENT TYPE (2020 V/S 2027) ($MN)
      • FIGURE 77     CHINA CARDIAC ASSIST DEVICES MARKET REVENUE, BY APPLICATION(2020 V/S 2027) ($MN)
      • FIGURE 78     INDIA CARDIAC ASSIST DEVICES (CAD) AND VENTRICULAR ASSIST DEVICES MARKET (VAD) REVENUE, BY PRODUCTS (2020 V/S 2027) ($MN)
      • FIGURE 79     INDIA CARDIAC ASSIST DEVICES MARKET REVENUE, BY IMPLANT TYPE/PUMP TYPE/PATIENT TYPE (2020 V/S 2027) ($MN)
      • FIGURE 80     INDIA CARDIAC ASSIST DEVICES MARKET REVENUE, BY APPLICATION (2020 V/S 2027) ($MN)
      • FIGURE 81     REST OF APAC CARDIAC ASSIST DEVICES (CAD) AND VENTRICULAR ASSIST DEVICES MARKET (VAD) REVENUE, BY PRODUCTS (2020 V/S 2027) ($MN)
      • FIGURE 82     REST OF APAC CARDIAC ASSIST DEVICES MARKET REVENUE, BY IMPLANT TYPE/PUMP TYPE/PATIENT TYPE (2020 V/S 2027) ($MN)
      • FIGURE 83     REST OF APAC CARDIAC ASSIST DEVICES MARKET REVENUE, BY APPLICATION (2020 V/S 2027) ($MN)
      • FIGURE 84     ROW CARDIAC ASSIST DEVICES MARKET SHARE, BY PRODUCTS, (2020 V/S 2027) (%)
      • FIGURE 85     ROW VENTRICULAR ASSIST DEVICES MARKET SHARE, BY PRODUCTS, (2020 V/S 2027) (%)
      • FIGURE 86     ROW CARDIAC ASSIST DEVICES MARKET SHARE, BY IMPLANT TYPE/PUMP TYPE/PATIENT TYPE (2020 V/S 2027) (%)
      • FIGURE 87     ROW CARDIAC ASSIST DEVICES MARKET REVENUE, BY PUMP TYPE AND CONTINUOUS FLOW PUMP TYPE (2020) ($MN)
      • FIGURE 88     ROW CARDIAC ASSIST DEVICES MARKET SHARE, BY PATIENT TYPE (2020 V/S 2027) (%)
      • FIGURE 89     ROW CARDIAC ASSIST DEVICES MARKET SHARE, BY APPLICATION (2020 V/S 2027) (%)
      • FIGURE 90     ROW CARDIAC ASSIST DEVICES MARKET SHARE, BY COUNTRY, (2020 V/S 2027) (%)
      • FIGURE 91     BRAZIL CARDIAC ASSIST DEVICES (CAD) AND VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY PRODUCTS (2020 V/S 2027) ($MN)
      • FIGURE 92     BRAZIL CARDIAC ASSIST DEVICES MARKET REVENUE, BY IMPLANT TYPE/PUMP TYPE/PATIENT TYPE (2020 V/S 2027) ($MN)
      • FIGURE 93     BRAZIL CARDIAC ASSIST DEVICES MARKET REVENUE, BY APPLICATION (2020 V/S 2027) ($MN)
      • FIGURE 94     REST OF LATIN AMERICA CARDIAC ASSIST DEVICES (CAD) AND VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY PRODUCTS (2020 V/S 2027) ($MN)
      • FIGURE 95     REST OF LATIN AMERICA CARDIAC ASSIST DEVICES MARKET REVENUE, BY IMPLANT TYPE/PUMP TYPE/PATIENT TYPE (2020 V/S 2027) ($MN)
      • FIGURE 96     REST OF LATIN AMERICA CARDIAC ASSIST DEVICES MARKET REVENUE, BY APPLICATION (2020 V/S 2027) ($MN)
      • FIGURE 97     MIDDLE EAST AND OTHERS CARDIAC ASSIST DEVICES (CAD) AND VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY PRODUCTS (2020 V/S 2027) ($MN)
      • FIGURE 98     MIDDLE EAST AND OTHERS CARDIAC ASSIST DEVICES MARKET REVENUE, BY IMPLANT TYPE/PUMP TYPE/PATIENT TYPE (2020 V/S 2027) ($MN)
      • FIGURE 99     MIDDLE EAST AND OTHERS CARDIAC ASSIST DEVICES MARKET REVENUE, BY APPLICATION (2020 V/S 2027) ($MN)
      • FIGURE 100     KEY GROWTH STRATEGIES, (2020-2021)
      • FIGURE 101     SWOT: ABBOTT LABORATORIES
      • FIGURE 102     SWOT: ABIOMED, INC.
      • FIGURE 103     SWOT: BERLIN HEART GMBH
      • FIGURE 104     SWOT: FRESENIUS MEDICAL CARE AG & CO. KGAA CARE (XENIOS AG)
      • FIGURE 105     SWOT: GETINGE GROUP (MAQUET)
      • FIGURE 106     SWOT: LIVANOVA, PLC
      • FIGURE 107     SWOT: MEDTRONIC, PLC
      • FIGURE 108     SWOT: SYNCARDIA SYSTEMS, LLC
      • FIGURE 109     SWOT: TELEFLEX INCORPORATED
      • FIGURE 110     SWOT: ZEON CORPORATION

      LIST OF COMPANIES MENTIONED IN THE REPORT

      • 1     ABBOTT LABORATORIES
      • 2     ABIOMED, INC.
      • 3     BALTON SP. Z O.O
      • 4     BERLIN HEART GMBH
      • 5     BIVACOR, INC.
      • 6     CALON CARDIO -TECHNOLOGY LTD
      • 7     CARDIOBRIDGE GMBH
      • 8     CARMAT SA
      • 9     CLEVELAND HEART, INC.
      • 10     CORWAVE S.A.
      • 11     EVAHEART, INC.
      • 12     FINEHEART SARL
      • 13     FRESENIUS MEDICAL CARE AG & CO. KGAA (XENIOS AG)
      • 14     GETINGE AB (MAQUET HOLDING)
      • 15     GPB LIFE SCIENCE HOLDINGS LLC (INSIGHTRA MEDICAL, INC.)
      • 16     JARVIK HEART, INC.
      • 17     LIVANOVA, PLC (TANDEM LIFE)
      • 18     MEDTRONIC, PLC
      • 19     MITIHEART CORPORATION
      • 20     OREGONHEART
      • 21     RELIANTHEART, INC.
      • 22     SENKO MEDICAL INSTRUMENT MFG. CO., LTD
      • 23     SYNCARDIA SYSTEMS, LLC
      • 24     TELEFLEX INCORPORATED
      • 25     WINDMILL CARDIOVASCULAR SYSTEMS, INC. (WCS)
      • 26     ZEON CORPORATION